dichlorotetrakis(dimethyl sulfoxide)ruthenium ii has been researched along with Adenocarcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alessio, E; Bergamo, A; Gava, B; Iengo, E; Sava, G; Sorc, A; Zorzet, S | 1 |
1 other study(ies) available for dichlorotetrakis(dimethyl sulfoxide)ruthenium ii and Adenocarcinoma
| Article | Year |
|---|---|
Effects of NAMI-A and some related ruthenium complexes on cell viability after short exposure of tumor cells.
Topics: Adenocarcinoma; Analysis of Variance; Animals; Antineoplastic Agents; Cell Survival; Dimethyl Sulfoxide; Flow Cytometry; Humans; Mice; Organometallic Compounds; Ruthenium Compounds; Tumor Cells, Cultured | 2000 |